1. Home
  2. BFRG vs CLGN Comparison

BFRG vs CLGN Comparison

Compare BFRG & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bullfrog AI Holdings Inc.

BFRG

Bullfrog AI Holdings Inc.

HOLD

Current Price

$0.67

Market Cap

6.9M

Sector

Technology

ML Signal

HOLD

Logo CollPlant Biotechnologies Ltd

CLGN

CollPlant Biotechnologies Ltd

HOLD

Current Price

$0.36

Market Cap

4.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFRG
CLGN
Founded
2017
2004
Country
United States
Israel
Employees
17
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Industrial Specialties
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.9M
4.9M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
BFRG
CLGN
Price
$0.67
$0.36
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$11.00
AVG Volume (30 Days)
280.0K
78.4K
Earning Date
05-12-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$240.45
Revenue Next Year
N/A
$38.03
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.43
$0.27
52 Week High
$2.04
$3.23

Technical Indicators

Market Signals
Indicator
BFRG
CLGN
Relative Strength Index (RSI) 47.59 36.04
Support Level $0.65 $0.29
Resistance Level $0.69 $0.45
Average True Range (ATR) 0.07 0.04
MACD 0.00 -0.00
Stochastic Oscillator 60.07 27.30

Price Performance

Historical Comparison
BFRG
CLGN

About BFRG Bullfrog AI Holdings Inc.

Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.

Share on Social Networks: